Cleared Traditional

K882447 - EPSTEIN-BARR VIRUS EARLY ANTIGEN (EA) ANTIBODY TES (FDA 510(k) Clearance)

Dec 1988
Decision
184d
Days
Class 1
Risk

K882447 is an FDA 510(k) clearance for the EPSTEIN-BARR VIRUS EARLY ANTIGEN (EA) ANTIBODY TES. This device is classified as a Epstein-barr Virus, Other (Class I - General Controls, product code LSE).

Submitted by Zeus Scientific, Inc. (Raritan, US). The FDA issued a Cleared decision on December 15, 1988, 184 days after receiving the submission on June 14, 1988.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3235.

Submission Details

510(k) Number K882447 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 14, 1988
Decision Date December 15, 1988
Days to Decision 184 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary

Device Classification

Product Code LSE — Epstein-barr Virus, Other
Device Class Class I - General Controls
CFR Regulation 21 CFR 866.3235